Fresh analysis suggests that individuals who stop using blockbuster weight-loss injections like Wegovy and Mounjaro can put back on reduced body mass much more quickly than those who halt traditional lifestyle plans.
Published data in a leading medical journal demonstrates that while obese people frequently drop a large proportion of their total mass while on the medication, the mass is regained at an estimated rate of nearly a kilo each month once they quit.
"People buying such treatments must be aware of the potential of quick weight regain when the medication ends," cautioned lead investigator Dr. Susan Jebb.
Such speed of recovery means a reversion to starting mass in about 18 months.
Weighing Treatments
The study, which reviewed 37 of trials involving over 9,000 of participants, contrasted the outcomes of these new drugs with conventional dieting.
The team point out that people who lose weight through lifestyle changes alone typically experience a more gradual weight regain—approximately 0.1 kg a month—after stopping.
Understanding the Rapid Rebound
Nutrition scientists propose the mode of action of the injections accounts for the accelerated rebound.
The injections imitate a natural hormone called GLP-1, which controls feelings of fullness.
"Artificially providing GLP-1 levels far above than normal might result in the body to generate a reduced amount of its own natural hormone, and may also reduce sensitivity to its actions," said Dr. Adam Collins, a nutrition researcher.
"Discontinuation of this medication results in appetite is no longer kept in check, making binge eating a significant risk."
A Chronic Issue?
The NHS suggest the jabs for people with weight-linked medical conditions, alongside prescribed diet and exercise modifications.
Professionals contend that, given the likelihood of relapse, the treatment should be considered long-term.
This opinion is echoed by pharmaceutical companies, who state that the results "emphasize the long-term character of obesity," similar to managing conditions like hypertension.
Patient Testimonies
Individuals who have stopped the jabs describe a powerful return of cravings.
"It was like a switch flipping and you're instantly ravenous," recalled a patient.
The struggle is worsened if individuals have not adopted lasting dietary or behavioural changes during therapy.
Widespread Interest
Recent estimates indicate that millions of people in the UK have used these injections in the past year, with demand being substantial.
- Use is greater among females than men.
- The 40s and 50s demographic shows the greatest usage rates.
- Many access the medications through private prescriptions rather than public health services.
Ultimately, experts emphasize that while GLP-1 drugs are effective agents for weight loss, they are not a magic fix and maintained weight loss relies on integrated lifestyle changes.